Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”?
McRae-McKee, Kevin, Udeh-Momoh, Chinedu T., Price, Geraint, Bajaj, Sumali, de Jager, Celeste A., Scott, David, Hadjichrysanthou, Christoforos, McNaughton, Emily, Bracoud, Luc, Ahmadi-Abhari, Sara, deLanguage:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2019.07.010
Date:
September, 2019
File:
PDF, 897 KB
english, 2019